Novo Nordisk (NYSE: NVO) was featured in a recent analysis report that discussed rocketing mentions of the company’s Ozempic drug (+86). “Ozempic (made by Novo Nordisk) currently holds a massive brand recognition lead when it comes to mention volume vs. other established brand names,” reads the report, written by LikeFolio Founder Andy Swan. The publication … Continue reading InvestorNewsBreaks – Novo Nordisk (NYSE: NVO) Featured in Analysis Report